# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

B-Cell Lymphomas

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 561-565 of 565 results.
Activated T Lymphocytes Expressing CARs, Relapsed CD19+ Malignancies Post-Allo HSCT(CARPASCIO)
Status: Recruiting
Last Changed: Jan 18, 2020
First Received: Jan 30, 2014
Disease(s): Non-Hodgkin's Lymphoma, B-Cell ALL, B-Cell CLL
Intervention(s): CD19.CAR-CD28Z T Cells - dose escalation 2, CD19.CAR-CD28Z T Cells - dose escalation 1
Locations: Houston Methodist Hospital, Houston, Texas, United States
Texas Children's Hospital, Houston, Texas, United States
CD19-directed CAR T Cells Therapy in Relapsed/Refractory B Cell Malignancy
Status: Recruiting
Last Changed: Dec 03, 2018
First Received: Sep 02, 2015
Disease(s): Leukemia, Lymphoma
Intervention(s): CD19-directed CAR-T cells
Locations: Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai, China
Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia
Status: Recruiting
Last Changed: Jul 27, 2020
First Received: Jun 19, 2019
Disease(s): Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma, Refractory B Acute Lymphoblastic Leukemia, Refractory B Lymphoblastic Lymphoma
Intervention(s): Etoposide, Doxorubicin, Vincristine, Prednisone, Cyclophosphamide, Inotuzumab Ozogamicin
Locations: Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Study to Assess Umbralisib Plus Ublituximab in Patients With Treatment Naïve Follicular Lymphoma
Status: Recruiting
Last Changed: Jul 08, 2020
First Received: Feb 04, 2019
Disease(s): Follicular Lymphoma, Small Lymphocytic Lymphoma
Intervention(s): Ublituximab, Umbralisib
Locations: TG Therapeutics Investigational Trial Site, Fort Myers, Florida, United States
TG Therapeutics Investigational Trial Site, Saint Petersburg, Florida, United States
TG Therapeutics Investigational Trial Site, Nashville, Tennessee, United States
A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase
Status: Recruiting
Last Changed: Jul 14, 2020
First Received: Feb 24, 2015
Disease(s): Lymphoma, Acute Lymphoblastic Leukemia
Intervention(s): Apixaban, No systemic anticoagulant prophylaxis
Locations: Phoenix Children'S Hospital/Ctr. For Cancer & Blood Ctr., Phoenix, Arizona, United States
City of Hope, Duarte, California, United States
Loma Linda University Cancer Center, Loma Linda, California, United States
Childrens Hospital Of La, Los Angeles, California, United States
Local Institution, Los Angeles, California, United States
... and 113 other locations.